CD8A and neoplasm: In addition, Schmidt et al. showed that SOAT inhibition could reduce neutral lipid droplets of CD8+ T cells, promote lipid microdomains, enhance TCR signal transduction and TCR-independent bioenergetics, and play an anti-tumor role [39].